Companies that reported the most in general payments in 2020
The 50 highest-ranked manufacturers and group purchasing organisations, by general payments for program year 2020, out of $2,193,409,441 of that kind reported across the whole year. A ranking is not a judgement, and this list is a slice of the year rather than all of it.
Ranked by reported value
50 shownDownload CSV · 50 rows Free, no sign-in. Raw amounts in U.S. dollars; the second row says where the data came from.
- Genentech, Inc. 9.5% of the year $208,754,247 · 1,903 payments
- Medtronic Vascular, Inc. 4.8% of the year $104,749,073 · 70,397 payments
- Arthrex, Inc. 4.1% of the year $89,884,572 · 20,420 payments
- Zimmer Biomet Holdings, Inc. 3.5% of the year $77,270,450 · 48,936 payments
- Stryker Corporation 3.5% of the year $75,628,985 · 59,457 payments
- AstraZeneca Pharmaceuticals LP 3.1% of the year $68,404,669 · 309,511 payments
- Medtronic USA, Inc. 3.1% of the year $67,312,456 · 49,705 payments
- Allergan Inc. 3.1% of the year $67,312,444 · 347,582 payments
- DePuy Synthes Products, Inc. 3% of the year $65,600,646 · 1,774 payments
- Medtronic MiniMed, Inc. 1.9% of the year $40,859,500 · 6,449 payments
- Intuitive Surgical, Inc. 1.7% of the year $37,848,233 · 50,206 payments
- Smith+Nephew, Inc. 1.6% of the year $33,908,840 · 38,870 payments
- Boston Scientific Corporation 1.5% of the year $33,833,711 · 87,297 payments
- Pfizer Inc. 1.3% of the year $28,888,467 · 189,084 payments
- AbbVie, Inc. 1.2% of the year $26,135,636 · 200,446 payments
- Lilly USA, LLC 1.2% of the year $25,990,254 · 180,753 payments
- Gilead Sciences, Inc. 1.2% of the year $25,603,752 · 40,531 payments
- Merck Sharp & Dohme Corporation 1.1% of the year $24,847,167 · 116,142 payments
- Abbott Laboratories 1.1% of the year $24,360,952 · 116,913 payments
- Genzyme Corporation 1.1% of the year $23,602,179 · 40,609 payments
- Amgen Inc. 1% of the year $21,868,029 · 231,485 payments
- Paragon 28, Inc. 0.9% of the year $20,486,429 · 1,829 payments
- Eisai Inc. 0.8% of the year $18,508,565 · 36,968 payments
- Takeda Pharmaceuticals U.S.A., Inc. 0.8% of the year $18,322,569 · 76,084 payments
- NuVasive, Inc. 0.8% of the year $17,555,051 · 7,816 payments
- GlaxoSmithKline, LLC. 0.8% of the year $17,205,617 · 190,942 payments
- Medical Device Business Services, Inc. 0.7% of the year $15,768,687 · 10,386 payments
- Anika Therapeutics, Inc. 0.7% of the year $15,741,211 · 319 payments
- Novo Nordisk Inc 0.7% of the year $15,227,775 · 261,554 payments
- Novartis Pharmaceuticals Corporation 0.7% of the year $14,935,651 · 130,319 payments
- Biogen, Inc. 0.7% of the year $14,687,894 · 21,572 payments
- CSL Behring 0.7% of the year $14,550,755 · 21,502 payments
- Encore Medical, LP 0.6% of the year $14,135,456 · 2,921 payments
- Hologic Inc 0.6% of the year $12,021,838 · 557 payments
- Globus Medical, Inc. 0.6% of the year $11,956,833 · 2,499 payments
- Wright Medical Technology, Inc. 0.5% of the year $11,814,797 · 6,036 payments
- Boehringer Ingelheim Pharmaceuticals, Inc. 0.5% of the year $11,497,368 · 121,417 payments
- LivaNova USA, Inc. 0.5% of the year $11,323,158 · 4,370 payments
- E.R. Squibb & Sons, L.L.C. 0.5% of the year $10,615,703 · 57,061 payments
- Janssen Pharmaceuticals, Inc 0.5% of the year $10,335,041 · 159,909 payments
- Ge Healthcare 0.4% of the year $9,439,581 · 4,236 payments
- Edwards Lifesciences Corporation 0.4% of the year $8,972,021 · 18,055 payments
- Siemens Medical Solutions USA, Inc. 0.4% of the year $8,577,733 · 3,586 payments
- Teva Pharmaceuticals USA, Inc. 0.4% of the year $7,867,802 · 64,306 payments
- Alcon Vision LLC 0.4% of the year $7,841,340 · 35,290 payments
- Celgene Corporation 0.4% of the year $7,836,904 · 9,232 payments
- Align Technology, Inc. 0.4% of the year $7,749,176 · 35,111 payments
- Covidien LP 0.4% of the year $7,603,842 · 7,969 payments
- Philips Electronics North America Corporation 0.3% of the year $7,224,015 · 15,787 payments
- Davol Inc. 0.3% of the year $6,989,113 · 5,649 payments